Join Dr. Sarah C. Rutherford, a lymphoma specialist, Dr. Carla Casulo, a clinician-scientist tackling relapsed follicular lymphoma, and Dr. Aaron Perry, a researcher focused on lymphoma biology. They delve into innovative treatment strategies like bispecific antibodies and CAR T-cell therapies. The conversation explores personalizing therapies based on patient history, the biology behind lymphoma transformation, and how emerging tools like ctDNA can guide treatment choices. Plus, they discuss the potential for cures and the complexities of managing high-risk cases.
